Cite
Fatal submassive hepatic necrosis associated with tyrosine-methionine-aspartate-aspartate-motif mutation of hepatitis B virus after long-term lamivudine therapy.
MLA
Kim, J. W., et al. “Fatal Submassive Hepatic Necrosis Associated with Tyrosine-Methionine-Aspartate-Aspartate-Motif Mutation of Hepatitis B Virus after Long-Term Lamivudine Therapy.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 33, no. 3, Aug. 2001, pp. 403–05. EBSCOhost, https://doi.org/10.1086/321879.
APA
Kim, J. W., Lee, H. S., Woo, G. H., Yoon, J. H., Jang, J. J., Chi, J. G., & Kim, C. Y. (2001). Fatal submassive hepatic necrosis associated with tyrosine-methionine-aspartate-aspartate-motif mutation of hepatitis B virus after long-term lamivudine therapy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 33(3), 403–405. https://doi.org/10.1086/321879
Chicago
Kim, J W, H S Lee, G H Woo, J H Yoon, J J Jang, J G Chi, and C Y Kim. 2001. “Fatal Submassive Hepatic Necrosis Associated with Tyrosine-Methionine-Aspartate-Aspartate-Motif Mutation of Hepatitis B Virus after Long-Term Lamivudine Therapy.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 33 (3): 403–5. doi:10.1086/321879.